Attention and memory deficits persist for months after recovery from mild Covid

19 January 2022

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Previous studies have shown that after acute Covid-19 infection some people can continue to suffer from cognitive symptoms such as difficulties in concentrating, colloquially referred to as brain fog, as well as forgetfulness and fatigue – features of the ‘long Covid’ syndrome.

But it was not known whether cognitive performance can also be affected in individuals who had mild symptoms and report no concerns after recovery from acute Covid infection.

In this study, participants were asked to complete a number of exercises to test their memory and cognitive ability, with a focus on cognitive functions critical for daily life, such as sustaining attention, memory, planning and semantic reasoning.

All the participants had previously suffered from Covid-19 but were not significantly different from a control group at the time of testing on factors such as fatigue, forgetfulness, sleep patterns or anxiety.

The researchers found that the participants performed well in most abilities tested, including working memory and planning, but they displayed significantly worse episodic memory (up to 6 months post-Covid infection) and a greater decline in the ability to sustain attention over time (for up to 9 months) than uninfected individuals.

Dr Sijia Zhao of the Department of Experimental Psychology, University of Oxford, said: “What is surprising is that although our Covid-19 survivors did not feel any more symptomatic at the time of testing, they showed degraded attention and memory. Our findings reveal that people can experience some chronic cognitive consequences for months.”

Professor Masud Husain said: “We still do not understand the mechanisms that cause these cognitive deficits, but it is very encouraging to see that these attention and memory return largely to normal in most people we tested by 6-9 months after infection, who demonstrated good recovery over time.”

Notes to editors

For further information, please contact:
Chris McIntyre in the University of Oxford press office at [email protected] or on +44 (0)1865 270 046

The full paper, “Rapid vigilance and episodic memory decrements in COVID-19 survivors” can be read in Brain Communications: https://doi.org/10.1093/braincomms/fcab295
https://academic.oup.com/braincomms/article-lookup/doi/10.1093/braincomms/fcab295

Oxford University’s Medical Sciences Division is one of the largest biomedical research centres in Europe, with over 2,500 people involved in research and more than 2,800 students. The University is rated the best in the world for medicine and life sciences, and it is home to the UK’s top-ranked medical school. It has one of the largest clinical study portfolios in the UK and great expertise in taking discoveries from the lab into the clinic. Partnerships with the local NHS Trusts enable patients to benefit from close links between medical research and healthcare delivery.

The University of Oxford
Oxford University has been placed number 1 in the Times Higher Education World University Rankings for the sixth year running, and 2 in the QS World Rankings 2022. At the heart of this success is our ground-breaking research and innovation.
Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research sparks imaginative and inventive insights and solutions.
Through its research commercialisation arm, Oxford University Innovation, Oxford is the highest university patent filer in the UK and is ranked first in the UK for university spinouts, having created more than 200 new companies since 1988. Over a third of these companies have been created in the past three years. The university is a catalyst for prosperity in Oxfordshire and the United Kingdom, contributing £15.7 billion to the UK economy in 2018/19, and supports more than 28,000 full time jobs.